DRREDDY - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.5
| Stock Code | DRREDDY | Market Cap | 1,03,290 Cr. | Current Price | 1,237 ₹ | High / Low | 1,380 ₹ |
| Stock P/E | 22.3 | Book Value | 378 ₹ | Dividend Yield | 0.65 % | ROCE | 25.8 % |
| ROE | 20.3 % | Face Value | 1.00 ₹ | DMA 50 | 1,231 ₹ | DMA 200 | 1,245 ₹ |
| Chg in FII Hold | -2.35 % | Chg in DII Hold | 2.45 % | PAT Qtr | 90.6 Cr. | PAT Prev Qtr | 387 Cr. |
| RSI | 54.9 | MACD | -6.14 | Volume | 9,60,495 | Avg Vol 1Wk | 12,92,011 |
| Low price | 1,020 ₹ | High price | 1,380 ₹ | PEG Ratio | 0.46 | Debt to equity | 0.13 |
| 52w Index | 60.4 % | Qtr Profit Var | -89.3 % | EPS | 55.6 ₹ | Industry PE | 29.1 |
📊 Analysis: DRREDDY is trading at 1,237 ₹, close to its 50 DMA (1,231 ₹) and 200 DMA (1,245 ₹), showing near-term support but medium-term weakness. RSI at 54.9 indicates neutral momentum, while MACD (-6.14) suggests mild bearish undertone. Current volume (9.6L) is below the 1-week average (12.9L), pointing to reduced intraday participation. The setup favors cautious trades with moderate upside potential.
💰 Optimal Buy Price: 1,230–1,240 ₹ (near support zone)
📈 Profit-Taking Levels: 1,255–1,270 ₹ (short-term resistance)
⚠️ Stop-Loss: 1,220 ₹ (below support)
⏳ If Already Holding: Exit intraday if price fails to sustain above 1,230 ₹ or if RSI dips below 53 with weakening momentum. Book profits near 1,255–1,270 ₹ if momentum slows. Watch MACD widening negatively as a clear exit signal.
Positive
- Strong ROCE (25.8%) and ROE (20.3%) indicate efficient capital use.
- Debt-to-equity ratio of 0.13 shows low leverage.
- DII holdings increased (+2.45%), reflecting domestic institutional support.
- EPS of 55.6 ₹ supports valuation strength.
- PEG ratio (0.46) indicates reasonable valuation relative to growth.
Limitation
- Trading below 200 DMA, showing medium-term weakness.
- MACD negative, indicating weak short-term momentum.
- Quarterly PAT dropped sharply (90.6 Cr. vs 387 Cr.), down 89.3%.
- FII holdings decreased (-2.35%), showing reduced foreign interest.
- Volume below average, limiting intraday opportunities.
Company Negative News
- No major external negative news reported, but sharp earnings decline and FII outflow are concerns.
Company Positive News
- DII holdings increased significantly, reflecting confidence from domestic institutions.
- Strong fundamentals with high ROCE and ROE despite recent earnings decline.
Industry
- Industry P/E at 29.1 is higher than DRREDDY’s P/E (22.3), suggesting relative undervaluation.
- Pharmaceutical sector remains resilient with global demand, though margins are pressured.
Conclusion
🔎 DRREDDY offers moderate intraday potential with support near 1,230 ₹ and resistance around 1,255–1,270 ₹. Momentum indicators suggest caution, as MACD is negative and volume is below average. Best strategy: Buy near support, exit near resistance, and protect downside with a strict stop-loss at 1,220 ₹.